Cargando…
Socio-economic costs of rare diseases and the risk of financial hardship: a cross-sectional study
BACKGROUND: To achieve universal healthcare coverage (UHC), the rare disease (RD) population must also receive quality healthcare without financial hardship. This study evaluates the impact of RDs in Hong Kong (HK) by estimating cost from a societal perspective and investigating related risk of fina...
Autores principales: | Chung, Claudia C.Y., Ng, Nicole Y.T., Ng, Yvette N.C., Lui, Adrian C.Y., Fung, Jasmine L.F., Chan, Marcus C.Y., Wong, Wilfred H.S., Lee, So Lun, Knapp, Martin, Chung, Brian H.Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240356/ https://www.ncbi.nlm.nih.gov/pubmed/37283971 http://dx.doi.org/10.1016/j.lanwpc.2023.100711 |
Ejemplares similares
-
Client Service Receipt Inventory as a standardised tool for measurement of socio-economic costs in the rare genetic disease population (CSRI-Ra)
por: Chung, Claudia C. Y., et al.
Publicado: (2021) -
Impact of COVID-19 pandemic on patients with rare disease in Hong Kong
por: Chung, Claudia CY., et al.
Publicado: (2020) -
Rapid whole-exome sequencing facilitates precision medicine in paediatric rare disease patients and reduces healthcare costs
por: Chung, Claudia C.Y., et al.
Publicado: (2020) -
POS-969 IMPACT OF VACCINATION ON CLINICAL OUTCOME OF HOSPITALISED END STAGE KIDNEY DISEASE PATIENTS WITH COVID-19 INFECTION. A SINGLE CENTRE EXPERIENCE
por: TEH, C.Y., et al.
Publicado: (2022) -
Modeling and Analyzing Gene Co-Expression in Hepatocellular Carcinoma Using Actor-Semiotic Networks and Centrality Signatures
por: Fung, David C.Y.
Publicado: (2008)